top of page
Phase III & Marketed Products
Discover OZQA’s collection of advanced SOP templates tailored for Phase III clinical trials and marketed pharmaceutical products.
These SOPs support the heightened regulatory requirements that apply in late-stage development and commercialisation, including GMP/GDP expectations, batch release processes, vendor oversight, quality system maturity, and post-marketing safety obligations.
Each template is professionally written, GxP-compliant, and ~95% pre-filled, making it easy to implement a robust Quality Management System that meets EMA, FDA, and ICH standards.
Discover OZQA’s collection of advanced SOP templates tailored for Phase III clinical trials and marketed pharmaceutical products.
These SOPs support the heightened regulatory requirements that apply in late-stage development and commercialisation, including GMP/GDP expectations, batch release processes, vendor oversight, quality system maturity, and post-marketing safety obligations.
Each template is professionally written, GxP-compliant, and ~95% pre-filled, making it easy to implement a robust Quality Management System that meets EMA, FDA, and ICH standards.…
13 Produkte
bottom of page